Finoriq research workspace
BIOMERICA INC (BMRA) SEC Filings & Filing Highlights
Biomerica, Inc., a biomedical technology company, engages in developing, patenting. Review BMRA SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
- Company
- BIOMERICA INC (BMRA)
- Ticker
- BMRA
- Market Cap
- $4.9M
- Latest Price
- $1.60
- Industry
- Diagnostics
BIOMERICA INC (BMRA) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BIOMERICA INC (BMRA).
| Event | Form | Date |
|---|---|---|
| Debt or FinancingDebt or Financing | 8-K2.03 | 2026-06-04 |
| BIOMERICA INC: Material agreementOn May 29, 2026 (the “Effective Date”), Biomerica, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreeme... | 8-K1.01 | 2026-06-04 |
| Broker Non-votesBiomerica, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) on December 12, 2025. As of Octobe... | 8-K5.07 | 2025-12-16 |
| NEWS - For Immediate ReleaseGary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors | 8-K7.01 | 2025-10-08 |
| Effective October 7, 2025, the Board of Directors (the “Board”) of Biomerica, Inc. (the “Compan...Effective October 7, 2025, the Board of Directors (the “Board”) of Biomerica, Inc. (the “Company”) elected to increase the size of the Boar... | 8-K5.02 | 2025-10-08 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.